way 123398 has been researched along with Leukemia, Myeloid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arcangeli, A; Balzi, M; Bartolozzi, B; Becchetti, A; Bernabei, PA; Brizzi, MF; Cherubini, A; Crociani, O; Guasti, L; Olivotto, M; Pegoraro, L; Pillozzi, S; Wanke, E | 1 |
1 other study(ies) available for way 123398 and Leukemia, Myeloid
Article | Year |
---|---|
HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors.
Topics: Acute Disease; Antigens, CD34; Benzimidazoles; Cation Transport Proteins; Cell Division; DNA-Binding Proteins; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Hematopoietic Stem Cells; Humans; Immunoenzyme Techniques; Leukemia, Myeloid; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Sulfanilamides; Trans-Activators; Transcriptional Regulator ERG; Tumor Cells, Cultured | 2002 |